Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 53 users online. 1 members and 52 guests.

Most users ever online was 3,930 at 06:07 PM on 04-20-2019.

109 results in 0.0086 seconds.
Keywords
Members
Tags
covid-19 x
  •  

  • Financial Action Task Force Adopts New Standards on Proliferation Financing

    Financial Action Task Force Adopts New Standards on Proliferation Financing

    Financial Action Task Force Adopts New Standards on Proliferation Financing, and advances work on COVID-19 AML/CFT Risks, and Trade-Based Money Laundering | site |


    (October 23, 2020) - - Today, October 23, 2020, the U.S. Department of the Treasury published the following information: WASHINGTON - The Financial Action Task Force (FATF) concluded its 32nd plenary meeting on Friday, October 23, by agreeing to revise its standards to further strengthen the global response to the financing of proliferation related to weapons of mass destruction. This week’s endorsement of the new standard is a result of an initiative that began under the U.S. FATF Presidency and Finance Ministers of FATF members adopted in 2019. The FATF also continued its focus on the impact of the COVID-19 pandemic on detecting and countering fraud including attempts to defraud government backed stimulus programs. The task force also adopted an updated report on trade-based money laundering and recogni...
    See more | Go to post

  • OCR Resolves Religious Discrimination Complaints, Patients Can Receive Safe Religious Visitations During COVID-19

    Office for Civil Rights Resolves Religious Discrimination Complaints after Maryland and Virginia Hospitals Ensure Patients Can Receive Safe Religious Visitations During COVID-19 | site |



    (October 20, 2020) - - The U.S. Department of Health and Human Services published today, October 20, 2020, the following information: Today, the Office for Civil Rights (OCR) at the U.S Department of Health and Human Services (HHS) announces the resolution of two religious discrimination complaints ensuring clergy access to patients for religious purposes during the COVID-19 pandemic, one involving MedStar’s Southern Maryland Hospital Center (MSMHC) that is part of the MedStar Health System, and the second one involving Mary Washington Healthcare (MWHC) in Virginia. In the first matter, in July 2020, OCR’s Conscience and Religious Freedom Division (CRFD) received a complaint from a mother alleging that after giving birth alone at MSMHC, she was separated from her newb...
    See more | Go to post

  • FDA Coronavirus (COVID-19) Update - - - Daily Roundup October 23, 2020

    FDA Coronavirus (COVID-19) Update - - - Daily Roundup October 23, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020
    | site |



    (October 23, 2020) - - Today, October 23, 2020, the U.S. Food and Drug Administration (FDA) published the following information:

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • On Thursday, the FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. The FDA revised the Emergency Use Authorization (EUA) for Veklury to remove those uses that are now approved under Gilead’s New Drug Application (NDA). The EUA for Veklury continues
    ...
    See more | Go to post

  • SBA Offers Disaster Assistance to Maryland Small Businesses Economically Impacted by the Coronavirus (COVID-19

    U.S. Small Business Administration Offers Disaster Assistance to Maryland Small Businesses Economically Impacted by the Coronavirus (COVID-19) | site |




    (October 20, 2020) - - Today, October 20, 2020, the U.S. Small Business Administration (SBA) published the following information:

    ATLANTA – The U.S. Small Business Administration is offering low-interest federal disaster loans for working capital to Maryland small businesses suffering substantial economic injury as a result of the Coronavirus (COVID-19), SBA Administrator Jovita Carranza announced today. SBA acted under its own authority, as provided by the Coronavirus Preparedness and Response Supplemental Appropriations Act that was recently signed by the President, to declare a disaster following a request received from Gov. Larry Hogan on March 18, 2020.

    The disaster declaration makes SBA assistance available in the entire state of Maryland; District of Columbia and the
    ...
    See more | Go to post

  • FDA Approves First Treatment for COVID-19

    FDA Approves First Treatment for COVID-19

    U.S. Food and Drug Administration Approves First Treatment for COVID-19 | site |




    (October 22, 2020) - - Today, October 22, 2020, the U.S. Food and Drug Administration (FDA) published the following information:

    Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval. This approval does not include the entire population that had been authorized to use Veklury under an Emergency Use Authorization (EUA) originally issued on May 1, 2020. In order to ensure continued access to the pediatric population previously covered und
    ...
    See more | Go to post

  • Johns Hopkins Covid-19 Story Tip - - - Lessons From A Disease Of Aging May Block Coronavirus Infection

    Johns Hopkins Covid-19 Story Tip: Lessons From A Disease Of Aging May Block Coronavirus Infection | site |




    (October 20, 2020) - - Today, October 20, 2020, Johns Hopkins Medicine published the following information:


    "Our researchers are studying a potential connection between #COVID-19 and a premature aging disease called progeria. An enzyme linked to progeria may be able to defend against the virus that causes COVID-19." (Quote from Johns Hopkins Medicine)


    An enzyme linked to a premature aging disease called progeria may also defend against viruses, including SARS-CoV-2, which causes COVID-19.

    The enzyme, called membrane-associated zinc metalloprotease ZMPSTE24, was discovered by the laboratory of Susan Michaelis, Ph.D. She has spent the last several decades studying the enzyme and its effect on a protein called lamin A, which is critical to maintaining the structure of the nucleus, a cell’s control center. M
    ...
    See more | Go to post

  • FDA Coronavirus (COVID-19) Update - - - Daily Roundup October 20, 2020

    FDA Coronavirus (COVID-19) Update - - - Daily Roundup October 20, 2020

    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: Daily Roundup October 20, 2020 | site |




    (October 20, 2020) - - Today, October 20, 2020, the U.S. Food and Drug Administration (FDA) published the following information:

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

    The FDA posted a new “FDA Insight” podcast featuring Deputy Commissioner Anand Shah, M.D., and Dr. Peter Marks, the Director of FDA's Center for Biologics Evaluation and Research, discussing the upcoming Vaccines and Related Biological Products Advisory Committee meeting on October 22, 2020.
    ...
    See more | Go to post

  • HHS says Trump Administration Partners with CVS and Walgreens to Provide COVID-19 Vaccine

    U.S. Dept. of Health and Human Services says Trump Administration Partners with CVS and Walgreens to Provide COVID-19 Vaccine to Protect Vulnerable Americans in Long-Term Care Facilities Nationwide | site |




    (October 16, 2020) - - Today, October 16, 2020, the U.S. Department of Health and Human Services (HHS) published the following information:

    To meet the Trump Administration's Operation Warp Speed (OWS) goals, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD exit disclaimer icon) today announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) nationwide with no out-of-pocket costs. Protecting especially vulnerable Americans has been a critical part of the Trump Administration’s work to combat COVID-19, and LTCF residents may be part of the prioritized groups for initial COVID-19 vaccination efforts until there are enough
    ...
    See more | Go to post

  • NIH begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19

    National Institutes of Health begins Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19 | site |





    (October 16, 2020) - - Today, October 16, 2020, The National Institutes of Health (NIH) published the following information:

    The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which the immune system unleashes excessive
    Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Graphic courtesy NIAID
    amounts of proteins that trigger inflammation — called a “cytokine storm” — that can lead to acute respiratory distress syndrome,...
    See more | Go to post

  • CMS Survey Data Illustrates Impact of COVID-19 on Medicare Beneficiaries’ Daily Life and Experiences

    Centers for Medicare and Medicaid Services Survey Data Illustrates Impact of COVID-19 on Medicare Beneficiaries’ Daily Life and Experiences | site |



    (October 16, 2020) - - The Centers for Medicare and Medicaid Services published today, October 16, 2020, the following information: Today, the Centers for Medicare & Medicaid Services (CMS) released data showing that 21% of Medicare beneficiaries report forgoing non-coronavirus disease 2019 (COVID-19) care due to the pandemic, and nearly all - 98% - of beneficiaries have taken preventative measures to keep themselves safe from the virus. According to the survey, the most common type of forgone care because of the pandemic was dental care (43%), followed by regular check-up (36%), treatment for ongoing condition (36%), and diagnostic or medical screening test (32%). The most common reason cited for forgoing care was not wanting to risk being at a medical facility (45%). Regarding COVID-19 preventative health behavi...
    See more | Go to post

  • U.S. Food and Drug Administration Coronavirus - - - COVID-19 - - - Update: Daily Roundup October 13, 2020

    U.S. Food and Drug Administration Coronavirus - - - COVID-19 - - - Update: Daily Roundup October 13, 2020 | site |


    (October 13, 2020) - - Today, October 13, 2020, the U.S. Food and Drug Administration published the following information:

    The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:
    ...
    See more | Go to post

  • BULLETIN—NIAID Stops Enrollment of Severely Ill COVID-19 Participants in Clinical Trial of Investigational Treatments

    BULLETIN—NIAID Stops Enrollment of Severely Ill COVID-19 Participants in Clinical Trial of Investigational Treatments | site |


    ACTT-3 Study Will Continue for Hospitalized Participants with Less Severe Illness


    Editor's note: Please note that this BULLETIN was published on September 29, 2020


    (September 29, 2020) - - On September 29, 2020, the National Institute of Allergy and Infectious Diseases published the following information:

    The Adaptive COVID-19 Treatment Trial 3 (ACTT-3), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will no longer enroll hospitalized participants with severe COVID-19 requiring high-flow oxygen, and will not begin to enroll patients requiring non-invasive or invasive mechanical ventilation. This action is being taken after an interim review of safety data by the study’s Data and Safety Monitoring Board (DSMB)
    ...
    See more | Go to post

  • NIH Study aims to Identify promising COVID-19 Treatments for larger Clinical Trials

    National Institutes of Health Study aims to Identify promising COVID-19 Treatments for larger Clinical Trials | site |



    (October 13, 2020) - - Today, the National Institutes of Health published the following information:

    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show




    This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S.
    Graphic courtesy NIAID

    promise against COVID-19 and merit...
    See more | Go to post

  • Announcement says Johnson & Johnson Temporarily Pauses All Dosing in their Janssen COVID-19 Vaccine Candidate Clinical Trials

    Announcement says Johnson & Johnson Temporarily Pauses All Dosing in their Janssen COVID-19 Vaccine Candidate Clinical Trials | site |



    (October 12, 2020) - - Today, October 12, 2020, Johnson & Johnson published the following information:



    Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials


    At Johnson & Johnson, there is no greater priority than the safety and well being of the people we serve every day around the world. We are committed to providing transparent updates throughout the clinical development process of our vaccine candidate, in compliance with regulatory standards and our own high ethical and scientific principles.

    We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant. Following our guidelines,
    ...
    See more | Go to post

  • U.S. Consumer Product Safety Commission says a COVID-19 Halloween Doesn’t Have to Be Scary

    U.S. Consumer Product Safety Commission Urges Families to Follow CDC Halloween Advice for Safe Celebrating; a COVID-19 Halloween Doesn’t Have to Be Scary | site |



    (October 6, 2020) - - Today, the U.S. Consumer Product Safety Commission (CPSC) published the following information:

    WASHINGTON, D.C. – The U.S. Consumer Product Safety Commission is urging families to follow Centers for Disease Control and Prevention (CDC) advice for Halloween this year. Among the key guidance: A Halloween mask is not an appropriate substitute for a protective cloth mask. CPSC joins with CDC in recommending that consumers wear a protective cloth mask of at least two layers of breathable fabric—not a costume mask. Protective masks should never be worn under a costume mask because it can become hard to breathe. If children or adults wear costumes this Halloween, be aware that costume fabrics and loose, billowy clothing (such as capes or gowns) can easily catch fire.
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    Financial Action Task Force Adopts New Standards on Proliferation Financing
    by Staff Reporter 1
    Financial Action Task Force Adopts New Standards on Proliferation Financing, and advances work on COVID-19 AML/CFT Risks, and Trade-Based Money Laundering | site |


    (October 23, 2020) - - Today, October 23, 2020, the U.S. Department of the Treasury published the following information: WASHINGTON - The Financial Action Task Force (FATF) concluded its 32nd plenary meeting on Friday, October 23, by agreeing to revise its standards to further strengthen the global response to the financing of proliferation related to weapons of mass destruction. This week’s endorsement of the new standard is a result of an initiative that began under the U.S. FATF Presidency and Finance Ministers of FATF members adopted in 2019. The FATF also continued its focus on the impact of the COVID-19 pandemic on detecting and countering fraud including attempts to defraud government backed stimulus programs. The task force also adopted an updated report on trade-based money laundering and recogni...
    10-25-2020, 04:21 AM
  • Staff Reporter 1
    OCR Resolves Religious Discrimination Complaints, Patients Can Receive Safe Religious Visitations During COVID-19
    by Staff Reporter 1
    Office for Civil Rights Resolves Religious Discrimination Complaints after Maryland and Virginia Hospitals Ensure Patients Can Receive Safe Religious Visitations During COVID-19 | site |



    (October 20, 2020) - - The U.S. Department of Health and Human Services published today, October 20, 2020, the following information: Today, the Office for Civil Rights (OCR) at the U.S Department of Health and Human Services (HHS) announces the resolution of two religious discrimination complaints ensuring clergy access to patients for religious purposes during the COVID-19 pandemic, one involving MedStar’s Southern Maryland Hospital Center (MSMHC) that is part of the MedStar Health System, and the second one involving Mary Washington Healthcare (MWHC) in Virginia. In the first matter, in July 2020, OCR’s Conscience and Religious Freedom Division (CRFD) received a complaint from a mother alleging that after giving birth alone at MSMHC, she was separated from her newb...
    10-25-2020, 02:38 AM
  • Staff Reporter 1
    FDA Coronavirus (COVID-19) Update - - - Daily Roundup October 23, 2020
    by Staff Reporter 1
    U.S. Food and Drug Administration Coronavirus (COVID-19) Update: Daily Roundup October 23, 2020
    | site |



    (October 23, 2020) - - Today, October 23, 2020, the U.S. Food and Drug Administration (FDA) published the following information:

    The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
    • On Thursday, the FDA approved Veklury (remdesivir), the first drug approved to treat COVID-19, for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. The FDA revised the Emergency Use Authorization (EUA) for Veklury to remove those uses that are now approved under Gilead’s New Drug Application (NDA). The EUA for Veklury continues
    ...
    10-24-2020, 12:19 AM
  • Staff Reporter 1
    SBA Offers Disaster Assistance to Maryland Small Businesses Economically Impacted by the Coronavirus (COVID-19
    by Staff Reporter 1
    U.S. Small Business Administration Offers Disaster Assistance to Maryland Small Businesses Economically Impacted by the Coronavirus (COVID-19) | site |




    (October 20, 2020) - - Today, October 20, 2020, the U.S. Small Business Administration (SBA) published the following information:

    ATLANTA – The U.S. Small Business Administration is offering low-interest federal disaster loans for working capital to Maryland small businesses suffering substantial economic injury as a result of the Coronavirus (COVID-19), SBA Administrator Jovita Carranza announced today. SBA acted under its own authority, as provided by the Coronavirus Preparedness and Response Supplemental Appropriations Act that was recently signed by the President, to declare a disaster following a request received from Gov. Larry Hogan on March 18, 2020.

    The disaster declaration makes SBA assistance available in the entire state of Maryland; District of Columbia and the
    ...
    10-23-2020, 11:35 AM
  • Staff Reporter 1
    FDA Approves First Treatment for COVID-19
    by Staff Reporter 1
    U.S. Food and Drug Administration Approves First Treatment for COVID-19 | site |




    (October 22, 2020) - - Today, October 22, 2020, the U.S. Food and Drug Administration (FDA) published the following information:

    Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval. This approval does not include the entire population that had been authorized to use Veklury under an Emergency Use Authorization (EUA) originally issued on May 1, 2020. In order to ensure continued access to the pediatric population previously covered und
    ...
    10-23-2020, 10:22 AM

Menu

Collapse

Menu

Collapse

Working...
X